ATI Pathophysiology Exam Related

Review ATI Pathophysiology Exam related questions and content

A patient being treated for tuberculosis is determined to be drug resistant. Which of the following medications will the patient be resistant to in the treatment of tuberculosis?

  • A. Isoniazid (INH) and rifampin
  • B. Carbamazepine (Tegretol) and phenytoin (Dilantin)
  • C. Dextroamphetamine (Dexedrine) and doxapram (Dopram)
  • D. Propranolol (Inderal) and sotalol (Betapace)
Correct Answer: A

Rationale: In the treatment of tuberculosis, drug resistance commonly develops against medications like Isoniazid (INH) and rifampin. These two drugs are key components of the standard anti-tuberculosis treatment regimen. Choices B, C, and D are unrelated medications that are not used in the treatment of tuberculosis. Carbamazepine and phenytoin are anticonvulsants, dextroamphetamine is a stimulant, and propranolol and sotalol are used for cardiovascular conditions.